| | COMPOUND: C07199 | |
Entry |
|
Name |
|
Formula |
C21H27N3O2
|
Exact mass |
353.2103
|
Mol weight |
353.46
|
Structure |
|
Remark |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N02 ANALGESICS
N02C ANTIMIGRAINE PREPARATIONS
N02CA Ergot alkaloids
N02CA04 Methysergide
D02357 Methysergide (USAN/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01483 5-HT1A-receptor agonist
DG00835 Methysergide
D02357 Methysergide
DG01964 Ergot alkaloid
DG01982 Antimigraine, ergot alkaloid
DG00835 Methysergide
D02357 Methysergide
Analgesic
DG01484 5-HT1B-receptor agonist
DG00835 Methysergide
D02357 Methysergide
DG01485 5-HT1D-receptor agonist
DG00835 Methysergide
D02357 Methysergide
DG01518 5-HT1B/1D-receptor agonist
DG00835 Methysergide
D02357 Methysergide
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Serotonin
HTR1A
D02357 Methysergide (USAN/INN)
HTR2
D02357 Methysergide (USAN/INN)
HTR7
D02357 Methysergide (USAN/INN)
|
Other DBs |
|
KCF data |
ATOM 26
1 C8y C 20.5900 -18.4751
2 C8y C 20.5607 -17.1215
3 C8y C 21.7278 -19.1637
4 C8y C 19.3528 -19.1637
5 C2y C 21.7510 -16.4446
6 C8x C 19.3762 -16.4387
7 C1x C 22.9240 -18.4985
8 C8x C 21.7278 -20.5349
9 N4y N 19.3528 -20.5349
10 C8x C 18.1917 -18.4868
11 C1y C 22.9240 -17.1332
12 C2x C 21.7628 -15.0792
13 C8x C 18.1917 -17.1215
14 C1a C 18.3668 -21.5212
15 N1y N 24.1843 -16.4620
16 C1y C 22.9414 -14.4081
17 C1x C 24.1260 -15.0965
18 C1a C 25.2872 -17.1449
19 C5a C 22.9355 -13.0309
20 N1b N 24.1202 -12.3482
21 O5a O 21.7510 -12.3482
22 C1c C 25.2989 -13.0251
23 C1b C 26.4834 -12.3425
24 C1b C 25.2932 -14.3906
25 C1a C 27.6680 -13.0194
26 O1a O 26.4777 -15.0792
BOND 29
1 1 2 1
2 1 3 1
3 1 4 2
4 2 5 1
5 2 6 2
6 3 7 1
7 3 8 2
8 4 9 1
9 4 10 1
10 5 11 1
11 5 12 2
12 6 13 1
13 9 14 1
14 11 15 1
15 12 16 1
16 15 17 1
17 15 18 1
18 16 19 1 #Up
19 19 20 1
20 19 21 2
21 20 22 1
22 22 23 1
23 22 24 1 #Up
24 23 25 1
25 24 26 1
26 7 11 1
27 8 9 1
28 10 13 2
29 16 17 1
|
|
» Japanese version
|
|